An international team of researchers has discovered what promises to be the on-off switch behind several major diseases. In the advance online edition of today’s Nature Medicine, scientists from Sainte-Justine Hospital Research Center, the Université de Montréal and the Institut national de la santé et de la recherche médicale (INSERM) in France report how the GPR91 receptor contributes to activate unchecked vascular growth that causes vision loss in common blinding diseases. (source: nouvelles.umontreal.ca)
|
